【序号】：1 【作者】：Okada H1, Inoue Y, Heya T, Ueno H, Ogawa Y, Toguchi H. 【题名】：Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. 【期刊】：Pharm Res. 【年、卷、期、起止页码】: 1991 Jun;8(6):787-91. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/1905810 【序号】：2 【作者】：Taguchi T1, Koyama H, Yayoi K, Wada T, Takatsuka Y, Sonoo H, Morimoto K, Tominaga T, Abe R, Enomoto K, et al. 【题名】：[Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group]. 【期刊】：Gan To Kagaku Ryoho. 【年、卷、期、起止页码】:1995 Mar;22(4):495-508. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/7887641 【序号】：3 【作者】：Niijima T1, Aso Y, Akaza H, Fujita K, Fuse H, Hosaka M, Isurugi K, Kamidono S, Katayama T, Kawabe K, et al. 【题名】：[Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR]. 【期刊】：Hinyokika Kiyo. 【年、卷、期、起止页码】:1990 Nov;36(11):1343-60. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/2126912 【序号】：4 【作者】：D'Souza S1, Faraj JA, Dorati R, DeLuca PP. 【题名】：A short term quality control tool for biodegradable microspheres. 【期刊】：AAPS PharmSciTech. 【年、卷、期、起止页码】:2014 Jun;15(3):530-41. doi: 10.1208/s12249-013-0052-0. Epub 2014 Feb 12. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/24519488 【序号】：5 【作者】：Mashayekhi R1, Mobedi H, Najafi J, Enayati M. 【题名】：In-vitro/In-vivo comparison of leuprolide acetate release from an in-situ forming plga system. 【期刊】：Daru. 【年、卷、期、起止页码】:2013 Jul 15;21(1):57. doi: 10.1186/2008-2231-21-57. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/23856431 【序号】：6 【作者】：Schoubben A1, Blasi P, Deluca PP. 【题名】：Effect of agitation regimen on the in vitro release of leuprolide from poly(lactic-co-glycolic) acid microparticles. 【期刊】：J Pharm Sci. 【年、卷、期、起止页码】:2012 Mar;101(3):1212-20. doi: 10.1002/jps.23029. Epub 2011 Dec 21. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/22189694 【序号】：7 【作者】：D'Souza SS1, Faraj JA, DeLuca PP. 【题名】：A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres. 【期刊】：AAPS PharmSciTech. 【年、卷、期、起止页码】:2005 Oct 31;6(4):E553-64. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/16408857 【序号】：8 【作者】：D'Souza SS1, DeLuca PP. 【题名】：Development of a dialysis in vitro release method for biodegradable microspheres. 【期刊】：AAPS PharmSciTech. 【年、卷、期、起止页码】:2005 Oct 6;6(2):E323-8. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/16353991 【序号】：9 【作者】：Periti P1, Mazzei T, Mini E. 【题名】：Clinical pharmacokinetics of depot leuprorelin. 【期刊】：Clin Pharmacokinet. 【年、卷、期、起止页码】:2002;41(7):485-504. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/12083977 【序号】：10 【作者】：Shameem M1, Lee H, DeLuca PP. 【题名】：A short term (accelerated release) approach to evaluate peptide release from PLGA depot- formulations. 【期刊】：AAPS PharmSci. 【年、卷、期、起止页码】:1999;1(3):E7. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/11741203 【序号】：11 【作者】：Okada H1. 【题名】：One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. 【期刊】：Adv Drug Deliv Rev. 1 【年、卷、期、起止页码】:1997 Oct 13;28(1):43-70. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/10837564 【序号】：12 【作者】：Verspyck E1, Marpeau L, Lucas C. 【题名】：Leuprorelin depot 3.75 mg versus lynestrenol in the preoperative treatment of symptomatic uterine myomas: a multicentre randomised trial. 【期刊】：Eur J Obstet Gynecol Reprod Biol. 【年、卷、期、起止页码】:2000 Mar;89(1):7-13. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/10733017 【序号】：13 【作者】：Tunn UW1, Bargelloni U, Cosciani S, Fiaccavento G, Guazzieri S, Pagano F. 【题名】：Comparison of LH-RH analogue 1-month depot and 3-month depot by their hormone levels and pharmacokinetic profile in patients with advanced prostate cancer. 【期刊】：Urol Int. 【年、卷、期、起止页码】:1998;60 Suppl 1:9-16; discussion 16-7. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/9563139 【序号】：14 【作者】：Takada S1, Ogawa Y. 【题名】：. 【期刊】：Nihon Rinsho. 【年、卷、期、起止页码】:1998 Mar;56(3):675-9. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/9549355 【序号】：15 【作者】：Saruki K1, Sekihara T, Mashimo M, Matsuo H, Sekiguchi H. 【题名】：Leuprorelin acetate blood levels and dialysance after the administration of sustained-release leuprorelin acetate in a dialysis case complicated by prostate cancer. 【期刊】：Prostate. 【年、卷、期、起止页码】:1998 Feb 15;34(3):191-4. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/9492847 【序号】：16 【作者】：Okada H1, Doken Y, Ogawa Y, Toguchi H. 【题名】：Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. 【期刊】：Pharm Res. 【年、卷、期、起止页码】:1994 Aug;11(8):1143-7. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/7971715 【序号】：17 【作者】：Okada H1, Doken Y, Ogawa Y, Toguchi H. 【题名】：Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs. 【期刊】：Pharm Res. 【年、卷、期、起止页码】:1994 Aug;11(8):1199-203. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/7971724 【序号】：18 【作者】：Toguchi H1. 【题名】：Formulation study of leuprorelin acetate to improve clinical performance. 【期刊】：Clin Ther. 【年、卷、期、起止页码】:1992;14 Suppl A:121-30. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/1606592 【序号】：19 【作者】：Asano M1, Fukuzaki H, Yoshida M, Kumakura M, Mashimo T, Yuasa H, Imai K, Yamanaka H. 【题名】：In vivo characteristics of low molecular weight copoly (D,L-lactic acid) formulations with controlled release of LH-RH agonist. 【期刊】：Biomaterials. 【年、卷、期、起止页码】:1989 Oct;10(8):569-73. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/2513891 【序号】：20 【作者】：Ogawa Y1, Okada H, Heya T, Shimamoto T. 【题名】：Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals. 【期刊】：J Pharm Pharmacol. 【年、卷、期、起止页码】:J Pharm Pharmacol. 1989 Jul;41(7):439-44. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/2570847
应助达人
赛默飞实验室产品焕新计划有奖调研！
【七月征文】不一YOUNG实验“猿”
报名开启：ICS2024第十三届光谱网络会议！
推荐收藏！盘点中药材及饮片检测解决方案
